If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCarclo Regulatory News (CAR)

Share Price Information for Carclo (CAR)

Share Price is delayed by 15 minutes
Get Live Data
33.00    0.55 (1.66%)
Bid:
32.60
Ask:
34.90
Spread: 2.30 (7.055%)
Market Cap: £24.23m
CAR Live PriceLast checked at - London Stock Exchange

Intraday Carclo Share Chart

AGM Trading Update

7 Sep 2017 07:00

RNS Number : 0390Q
Carclo plc
07 September 2017
 

 

7 September 2017

Carclo plc

 ("Carclo" or the "Group")

AGM Trading Update

 

The Board announces that overall the Group's trading performance for the year ending 31 March 2018 remains in line with its expectations, with an outperformance of the LED Technologies division expected to offset the weaker than previously anticipated performance of the Technical Plastics division.

 

Technical Plastics has had a challenging start to the financial year with some key new programmes delayed into the second half and some operational challenges, which have now been largely resolved. Performance is now much improved and we expect this division to have a considerably better second half of the year, in line with our prior plans for that period. The new factory build in India and the redevelopment of Mitcham are progressing according to plan and the Chinese business is benefitting from further systems validations with our main medical customer as well as very strong new business opportunities.

 

LED Technologies is having an encouraging first half, performing ahead of our expectations, with its Wipac business seeing good product sales on its various supercar lighting programmes and strong design, development and tooling activity. New business activity has continued apace, and ahead of prior expectations. Progress on the mid-volume programmes and the factory expansion at Buckingham has continued to plan. Customer audits of our mid volume programmes have confirmed that we are well advanced with preparations for manufacturing and continuing to meet their high expectations. Integration of our recent Czech acquisition has been excellent and we are now starting to expand our technical teams in this location, which has already enhanced our ability to win more business.

 

The Aerospace division is expected to have stronger sales in the second half of the financial year as some of our new programmes move to serial production.

 

As anticipated, Group net debt will be higher at 30 September 2017 compared to 31 March 2017, primarily due to the timing of capital investment and an increase in working capital due to the investment and payment profile of ongoing design, development and tooling programmes. Group net debt is then expected to decrease by the year end.

 

Given the above, the Board anticipates that the Group's usually stronger second half performance weighting will this year be more pronounced, driven by an outperformance at LED Technologies and an improved performance at Technical Plastics. The Board continues to expect the Group to deliver results for the year as a whole in line with its previous expectations and is confident that all divisions are well placed to make strong progress thereafter.

 

The information contained within this announcement is deemed by Carclo plc to constitute inside information as stipulated under the Market Abuse Regulation. Upon the publication of this announcement via a regulatory information service, this inside information is now considered to be in the public domain.

- ENDS -

 

 

 

Enquiries:

 

Carclo plc

 

01924 268040

Chris Malley, Chief Executive

 

 

Robert Brooksbank, Finance Director

 

 

 

 

 

Peel Hunt LLP

 

0207 418 8900

Justin Jones

 

 

Matthew Brooke-Hitching

 

 

 

 

 

Weber Shandwick

Nick Oborne

Tom Jenkins

 

020 7067 0000

About Carclo

Carclo plc is a public company whose shares are quoted on the Main Market of the London Stock Exchange.

 

Carclo's strategy is to develop and expand its key manufacturing assets in markets where there remain significant further opportunities to drive shareholder value. To enhance profit margins and support its customers, the group has been investing across its global footprint.

 

Approximately three fifths of Group revenues are generated from the supply of fine tolerance, injection moulded plastic components, mainly for medical products. The balance of Group revenue is derived mainly from the design and supply of specialised injection moulded LED based lighting systems to the premium automotive industry.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCUGUCCBUPMGQQ
Date   Source Headline
25th Jun 20217:00 amRNSNotice of Preliminary Results
7th May 20214:26 pmRNSHolding(s) in Company
27th Apr 20217:00 amRNSFull Year Trading Update
22nd Apr 20219:13 amRNSHolding(s) in Company
25th Feb 202110:32 amRNSHolding(s) in Company
24th Feb 202110:31 amRNSHolding(s) in Company
22nd Feb 202110:28 amRNSHolding(s) in Company
18th Feb 202111:19 amRNSHolding(s) in Company
12th Feb 20217:00 amRNSAppointment of Director and CFO
5th Feb 20217:00 amRNSDirector/PDMR Shareholding
4th Feb 20214:35 pmRNSPrice Monitoring Extension
4th Feb 20214:15 pmRNSDirector/PDMR Shareholding
3rd Feb 20214:41 pmRNSSecond Price Monitoring Extn
3rd Feb 20214:35 pmRNSPrice Monitoring Extension
22nd Jan 20217:00 amRNSDirector Appointment
8th Jan 20217:00 amRNSDirector Appointment
7th Jan 202111:35 amRNSDirector/PDMR Shareholding
5th Jan 20214:40 pmRNSDirector/PDMR Shareholding
23rd Dec 20207:00 amRNSFramework Agreement
15th Dec 202010:07 amRNSAppointment of Interim CFO
27th Nov 20207:01 amRNSBoard Changes
27th Nov 20207:00 amRNSHalf Year Results
26th Nov 20204:41 pmRNSSecond Price Monitoring Extn
26th Nov 20204:35 pmRNSPrice Monitoring Extension
12th Nov 20204:33 pmRNSNotice of Interim Results
10th Nov 20204:41 pmRNSSecond Price Monitoring Extn
10th Nov 20204:36 pmRNSPrice Monitoring Extension
5th Oct 20207:00 amRNSBoard restructure
2nd Oct 20204:41 pmRNSSecond Price Monitoring Extn
2nd Oct 20204:36 pmRNSPrice Monitoring Extension
30th Sep 20207:00 amRNSAppointment of Non-Executive Chairman
29th Sep 202012:18 pmRNSResult of AGM
4th Sep 202011:04 amRNS2020 Annual Report & Accounts & Notice of 2020 AGM
25th Aug 20204:46 pmRNSDirector/PDMR Shareholding
25th Aug 20207:00 amRNSPreliminary Results for the year ended 31 March 20
18th Aug 20207:00 amRNSAppointment of NED and Chairman-elect
17th Aug 20207:00 amRNSUpdate on refinancing and current trading
4th May 20204:41 pmRNSSecond Price Monitoring Extn
4th May 20204:35 pmRNSPrice Monitoring Extension
4th May 20207:00 amRNSFull Year Trading Statement and COVID-19 Update
1st May 20204:24 pmRNSHolding(s) in Company
28th Apr 20204:41 pmRNSSecond Price Monitoring Extn
28th Apr 20204:37 pmRNSPrice Monitoring Extension
27th Apr 20207:00 amRNSAppointment of Chairman
14th Apr 20202:41 pmRNSExternal Auditor Appointment
8th Apr 20202:39 pmRNSHolding(s) in Company
8th Apr 20209:03 amRNSHolding(s) in Company
6th Apr 20201:35 pmRNSHolding(s) in Company
3rd Apr 202011:40 amRNSHolding(s) in Company
30th Mar 20204:40 pmRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.